How to transfer my Mounjaro prescription to

If you’ve been considering prescription weight loss medication like Wegovy, Ozempic, or Mounjaro, you may be wondering: Can I get these medications through telehealth, or do I need to visit a doctor in person?

The short answer is yes—in most cases, you can legally receive these medications through a telehealth consultation. But the details depend on where you live, who prescribes your medication, and whether you meet the clinical criteria for treatment.

This guide breaks down everything you need to know about accessing GLP-1 weight loss medications via telehealth in 2025, including federal regulations, state-specific rules, provider qualifications, and what to expect during your virtual visit.

Understanding the Legal Framework: Federal Rules for Telehealth Prescribing

GLP-1 Medications Are Not Controlled Substances

Here’s the most important thing to understand: Wegovy, Ozempic, and Mounjaro are not controlled substances under federal law. This means they’re not subject to the same strict prescribing rules that apply to medications like Adderall or opioids.

The federal Ryan Haight Act—which typically requires an in-person examination before prescribing controlled substances via telehealth—does not apply to GLP-1 medications. Under federal law, healthcare providers can prescribe these weight loss medications after establishing a valid patient-provider relationship through a telehealth video consultation.

What About the DEA’s Telehealth Rules?

You may have heard about the DEA’s temporary pandemic-era telehealth flexibilities. While these rules are important for medications like ADHD stimulants or buprenorphine (for opioid use disorder), they don’t affect GLP-1 weight loss medications because those drugs aren’t controlled.

That said, it’s worth noting that as of December 2025, the DEA has extended its telehealth prescribing flexibilities for controlled substances through December 31, 2025. Congress is also considering legislation (like the TREATS Act) to make some telehealth prescribing rules permanent—a sign that telemedicine is here to stay.

Bottom line: Federal law fully supports telehealth prescribing of weight loss medications like Wegovy and Ozempic, with no in-person visit required at the federal level.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Differences: Where Things Get Specific

While federal law gives telehealth prescribing a green light, individual states have their own rules—and these can vary significantly.

States That Require an Initial In-Person Visit

Some states require patients to have at least one in-person examination before (or shortly after) starting telehealth treatment for weight loss. These include:

• Arkansas: One of the most restrictive states for telehealth; requires an initial in-person exam to establish a valid doctor-patient relationship
• Delaware: Mandates an initial physical examination before prescribing weight loss medications
• Georgia: Requires an in-person baseline evaluation
• Mississippi: Expects an initial in-person visit for weight management therapy
• New Jersey: Requires a comprehensive in-person exam plus lab work before prescribing
• North Dakota: Expects a hands-on initial evaluation
• South Carolina: Mandates an initial in-person visit and periodic evaluations
• Texas: Standard of care typically requires an initial in-person exam
• Utah: Encourages an initial in-person assessment
• Virginia: Requires an initial physical exam, lab work, and a follow-up within 30 days of starting therapy

States With Full Telehealth Access (No In-Person Requirement)

Many states allow weight loss medications to be prescribed entirely via telehealth, with no in-person visit required:

• California
• Connecticut (requires behavioral counseling and lifestyle plan)
• Florida (though BMI ≥30 required and follow-ups every 3 months)
• Illinois
• New York
• Pennsylvania
• Washington

These states recognize that a thorough telehealth evaluation—including medical history review, current health assessment, and ongoing monitoring—can meet the standard of care for prescribing these medications.

Special State Requirements to Know

Beyond in-person visit requirements, some states have additional rules:

Florida: Patients must have a BMI of at least 30 and be seen (in-person or via telehealth) at least once every three months during treatment.

Connecticut: Providers must include behavioral counseling and a comprehensive diet and exercise plan as part of obesity treatment.

New Jersey & Virginia: Both require extensive initial workups including physical exam, laboratory testing, psychological screening, and a personalized lifestyle modification plan.

Who Can Prescribe? Understanding Provider Qualifications

Medical Doctors and Doctors of Osteopathy

MDs and DOs (medical doctors and doctors of osteopathic medicine) can prescribe weight loss medications via telehealth in all states, provided they’re licensed in the state where you’re located during your appointment.

Nurse Practitioners and Physician Assistants

Nurse Practitioners (NPs) and Physician Assistants (PAs) can also prescribe these medications, but their level of independence varies by state:

Full Independent Practice (34 states + DC): In states like Washington, California, New York, Arizona, and Utah, NPs can prescribe weight loss medications completely independently, without physician oversight.

Collaborative Practice: In states like Texas, Florida, Pennsylvania, Illinois, and Georgia, NPs and PAs must work under a physician’s supervision or collaborative agreement. This doesn’t mean the physician needs to be present during your telehealth visit, but there must be an established working relationship.

Recently Expanded Authority: Georgia passed legislation in 2024 allowing NPs and PAs to prescribe Schedule II controlled substances with physician delegation for the first time—a sign that prescribing authority is expanding in traditionally restrictive states.

When you work with a reputable telehealth provider like Klarity Health, you can trust that all prescribers—whether physicians or advanced practice providers—are properly licensed, credentialed, and authorized to prescribe in your state.

The Medications: What You Need to Know

Wegovy (Semaglutide 2.4mg)

• FDA Status: Approved specifically for chronic weight management
• Eligibility: BMI ≥30, or BMI ≥27 with weight-related health conditions (diabetes, hypertension, high cholesterol)
• Telehealth: Fully prescribable via telehealth in most states
• Important Note: As of May 2025, the FDA ended the shortage declaration and banned most compounded versions of semaglutide. You should only receive FDA-approved Wegovy from licensed pharmacies.

Ozempic (Semaglutide 0.5–1mg)

• FDA Status: Approved for Type 2 diabetes (used off-label for weight loss)
• Telehealth: Can be prescribed via telehealth, but providers must document the off-label use and obtain your informed consent
• Same active ingredient as Wegovy: Never combine with other semaglutide products

Mounjaro (Tirzepatide) and Zepbound

• FDA Status: Mounjaro approved for Type 2 diabetes; Zepbound (same drug, higher dose) approved for obesity in late 2023
• Telehealth: Fully prescribable via telehealth when clinically appropriate
• Special consideration: Self-injection medication requiring patient training

What to Expect During Your Telehealth Appointment

The Initial Consultation

A legitimate telehealth weight loss consultation will be thorough—not a quick questionnaire. Here’s what to expect:

Medical History Review: You’ll provide detailed information about your health history, current medications, allergies, and any previous weight loss attempts.

Current Health Assessment: You’ll discuss your current weight, height (to calculate BMI), diet and exercise habits, and any weight-related health concerns like prediabetes or joint problems.

Contraindication Screening: Your provider will screen for conditions that make GLP-1 medications unsafe, including:

• Personal or family history of medullary thyroid cancer
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Pregnancy or plans to become pregnant
• History of pancreatitis
• Severe gastrointestinal disorders
• Active gallbladder disease

Lab Work: Depending on your state and medical history, you may need baseline lab tests (metabolic panel, A1C, thyroid function) either before or shortly after starting treatment.

Treatment Plan Discussion: Your provider will explain how the medication works, potential side effects (nausea, GI upset, injection site reactions), and the importance of combining medication with lifestyle changes.

Informed Consent: Many states require specific documentation that you understand the risks and benefits of weight loss medication therapy.

Ongoing Monitoring and Follow-Up

Weight loss medication isn’t a one-and-done prescription. Reputable telehealth providers schedule regular follow-ups:

• First follow-up: Usually within 2-4 weeks of starting medication
• Ongoing visits: Every 1-3 months to monitor progress, adjust dosage, and assess side effects
• Lab monitoring: Periodic blood work to ensure medication safety

Some states mandate specific follow-up schedules. For example, Florida requires at least one visit every three months, and Virginia requires a check-in within 30 days of starting therapy.

At Klarity Health, we prioritize your safety with regular monitoring, transparent pricing whether you use insurance or pay cash, and providers available in your state to ensure you receive the ongoing care you need throughout your weight loss journey.

Red Flags: How to Spot Unsafe Telehealth Services

Unfortunately, the popularity of GLP-1 medications has attracted some questionable operators. Be cautious of any service that:

❌ Guarantees you a prescription before evaluating your medical history

❌ Offers ‘compounded’ semaglutide or overseas versions (FDA banned most compounding in 2025 due to safety concerns)

❌ Doesn’t require a video consultation with a licensed provider

❌ Skips follow-up appointments or doesn’t monitor your progress

❌ Isn’t transparent about which state the provider is licensed in

❌ Promises unrealistic results like ‘lose 30 pounds in a month’

❌ Doesn’t discuss side effects, contraindications, or lifestyle modifications

Green Flags of Reputable Services

✅ Requires a comprehensive medical questionnaire and live video consultation

✅ Employs licensed providers (MD, DO, NP, or PA) in your state

✅ Discusses both benefits and risks of medication

✅ Requires baseline health information and may request lab work

✅ Schedules regular follow-up appointments

✅ Prescribes only FDA-approved medications through licensed pharmacies

✅ Emphasizes the importance of diet and exercise alongside medication

✅ Has transparent pricing and accepts both insurance and self-pay options

Cost Considerations: Insurance vs. Cash Pay

Insurance Coverage

Many insurance plans now cover FDA-approved weight loss medications like Wegovy and Zepbound, though coverage varies:

• Medicare: Does not currently cover weight loss medications (though this may change with pending legislation)
• Medicaid: Coverage varies by state
• Private insurance: Many plans cover these medications, but may require prior authorization and proof that you’ve tried lifestyle modifications

Even with insurance, you may face high copays or deductibles. Some telehealth platforms can help navigate prior authorization and find manufacturer savings programs.

Cash Pay Options

If you don’t have insurance coverage, cash prices for these medications can be substantial:

• Wegovy: $1,300+ per month without insurance
• Ozempic: $900+ per month
• Mounjaro/Zepbound: $1,000+ per month

The telehealth visit itself is typically much more affordable, ranging from $49-$199 for an initial consultation and $29-$99 for follow-ups. Some providers like Klarity Health offer transparent, straightforward pricing and can work with you whether you’re using insurance or paying out of pocket.

The Clinical Reality: Who Actually Qualifies?

Common Misconceptions

Myth: ‘Anyone can get Ozempic online for quick weight loss.’

Reality: Reputable providers carefully screen patients. These medications are intended for people with obesity or significant weight-related health conditions—not for losing a few vanity pounds.

Typical Eligibility Criteria

Most providers follow these guidelines:

• BMI ≥30 (obesity), OR
• BMI ≥27 with at least one weight-related health condition (Type 2 diabetes, hypertension, high cholesterol, sleep apnea)
• Age 18+ (some medications approved for 12+ with parental consent)
• No contraindications (see list above)
• Willingness to commit to lifestyle changes (diet, exercise) alongside medication
• Previous weight loss attempts (some insurers and providers prefer to see you’ve tried lifestyle modification first)

If you don’t meet these criteria, a legitimate telehealth provider will likely recommend starting with lifestyle modifications, nutrition counseling, or exploring other options.

Setting Realistic Expectations

These medications work gradually. In clinical trials:

• Patients on Wegovy lost an average of 15% of body weight over 68 weeks
• Results vary significantly between individuals
• Weight loss requires ongoing medication (most people regain weight if they stop)
• Side effects are common, especially in the first few weeks

A good telehealth provider will set these realistic expectations upfront rather than promising dramatic overnight results.

Looking Ahead: The Future of Telehealth Weight Loss Treatment

Regulatory Trends Point to Continued Access

The trajectory is clear: telehealth access to weight loss medications is expanding, not contracting. Here’s why:

Proven Effectiveness: Telehealth-delivered obesity care has shown comparable outcomes to in-person treatment when proper protocols are followed.

Access Gaps: Traditional weight loss clinics are often concentrated in urban areas, leaving rural and underserved communities with few options. Telehealth bridges this gap.

Policy Momentum: Federal legislation like the TREATS Act and state-level reforms show bipartisan support for maintaining and expanding telehealth access.

Economic Pressure: The obesity epidemic costs the U.S. healthcare system billions annually. Effective treatment access can reduce these costs.

What to Watch in 2026

DEA Telemedicine Rules: While not directly affecting GLP-1 drugs, the DEA is expected to finalize permanent telehealth prescribing rules for controlled substances—signaling federal commitment to telemedicine.

State Licensing Compacts: More states are joining interstate compacts, making it easier for providers to treat patients across state lines.

NP Independence: Several states (including Mississippi and Pennsylvania) are considering legislation to grant nurse practitioners full independent practice authority, which would expand the telehealth provider pool.

New Medications: Additional weight loss medications are in the FDA pipeline, which will further expand telehealth treatment options.

Insurance Expansion: There’s growing pressure on insurers (including Medicare) to cover these medications, which would make telehealth treatment more affordable.

State-Specific Telehealth Requirements: Quick Reference

Note: Even in states requiring initial in-person visits, many allow you to complete that visit and then continue with telehealth follow-ups.

Frequently Asked Questions

Do I need to have a video visit, or can I just fill out a form?

A live video consultation is required in most states to establish a valid patient-provider relationship. Text-only or questionnaire-only prescribing typically doesn’t meet the legal standard of care for prescription medications.

What if I travel or move to another state?

Your prescribing provider must be licensed in the state where you are physically located during the appointment. If you move permanently, you’ll need to transfer care to a provider licensed in your new state. Many telehealth platforms work in multiple states to make this easier.

Can my regular doctor prescribe these medications via telehealth?

Yes, if your existing doctor offers telehealth services and is comfortable prescribing weight loss medications. However, many primary care physicians prefer to focus on other aspects of care and may refer you to a specialist or telehealth platform that specializes in weight management.

How long do I need to stay on the medication?

These medications are intended for long-term use. In clinical trials, most people regain weight when they stop taking the medication. Your provider will work with you to determine the appropriate duration based on your health goals and response to treatment.

What if I experience side effects?

Common side effects like nausea usually improve after the first few weeks. Your telehealth provider should be available to discuss any side effects and adjust your dose or treatment plan if needed. Severe side effects (like severe abdominal pain, signs of pancreatitis, or allergic reactions) require immediate medical attention.

Is compounded semaglutide legal?

As of May 2025, the FDA ended most compounding exceptions for semaglutide. You should only use FDA-approved Wegovy or Ozempic from licensed pharmacies. Compounded versions may not be tested for safety or efficacy and could be dangerous.

Taking the Next Step: What You Should Do

If you’re considering weight loss medication through telehealth, here’s your action plan:

1. Check your eligibility: Calculate your BMI and consider whether you have weight-related health conditions. Most online BMI calculators can give you a quick answer.

2. Research providers: Look for established telehealth platforms with licensed providers in your state, transparent pricing, and a focus on ongoing care—not just one-time prescriptions.

3. Gather your information: Before your appointment, compile your medical history, current medications, and any relevant lab work you already have.

4. Prepare questions: Write down what you want to know about the medication, treatment timeline, cost, and follow-up requirements.

5. Set realistic goals: Remember that these medications work best alongside lifestyle changes. Be ready to commit to healthier eating and increased physical activity.

6. Verify insurance coverage: If you plan to use insurance, contact your insurer to understand coverage, prior authorization requirements, and out-of-pocket costs.

7. Schedule your consultation: Choose a provider that fits your needs and schedule your initial appointment.

Why Choose Klarity Health for Weight Loss Medication

At Klarity Health, we make accessing weight loss medication straightforward, safe, and supportive:

✅ Licensed providers available in your state: Our board-certified physicians, nurse practitioners, and physician assistants are licensed and ready to help you meet your health goals.

✅ Transparent pricing: Whether you choose to use insurance or pay cash, you’ll know exactly what to expect—no surprise bills or hidden fees.

✅ Both insurance and self-pay accepted: We work with major insurance plans and offer affordable self-pay options for those without coverage.

✅ Comprehensive care: We don’t just prescribe—we provide ongoing monitoring, lifestyle coaching resources, and adjustments as needed.

✅ Convenient appointments: Schedule and attend your appointment from anywhere with our easy-to-use telehealth platform.

✅ Proper screening and safety: We follow evidence-based protocols to ensure you’re a good candidate for treatment and monitor for any concerns.

Ready to explore whether telehealth weight loss medication is right for you? Schedule a consultation with Klarity Health today and take the first step toward sustainable weight loss with expert guidance and support.

Final Thoughts

Yes, you absolutely can get weight loss medications like Wegovy, Ozempic, and Mounjaro through telehealth—safely and legally—in most states. While some states require an initial in-person visit or have specific protocols, telehealth has become a mainstream, effective way to access these medications with proper medical oversight.

The key is working with a reputable provider who prioritizes your safety through thorough evaluations, ongoing monitoring, and evidence-based treatment plans. Avoid services that promise easy prescriptions without proper assessment, and remember that medication is most effective when combined with lifestyle modifications.

Telehealth isn’t just convenient—it’s expanding access to effective obesity treatment for millions of Americans who previously faced barriers to care. Whether you live in a rural area without nearby specialists, have mobility limitations, or simply prefer the convenience of virtual care, telehealth puts expert weight management support within reach.

The regulatory landscape continues to evolve in favor of expanded access, and as more research confirms the effectiveness of telehealth-delivered care, we expect even fewer barriers in the years ahead.

References

1. DEA Announcement (November 2024) – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025’ (www.dea.gov)

2. Axios News – ‘COVID-era telehealth prescribing extended’ (November 18, 2024) (www.axios.com)

3. McDermott Will & Emery – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025’ (November 18, 2024) (www.mwe.com)

4. Goodwin Procter – ‘The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs’ (March 27, 2024) (www.goodwinlaw.com)

5. Reuters – ‘Telehealth company Hims to cut 4% of workforce amid ban on weight loss drug copies’ (May 30, 2025) (www.reuters.com)

📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of December 2025)
Sources newer than 2024: 15 of 18 sources (most sources are 2024–2025)

This article is for informational purposes only and does not constitute medical advice. Consult with a licensed healthcare provider to determine the most appropriate treatment for your individual situation.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid